Objective To assess health-related quality of life (HRQOL) in a large multicenter cohort of children and young adults with Marfan syndrome participating in the Pediatric Heart Network Marfan Trial.
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ORIGINAL ARTICLES shown significant impairment in a variety of HRQOL domains. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] The Pediatric Heart Network (PHN) conducted a randomized trial to compare the effects of atenolol and losartan on the rate of aortic root enlargement in children and young adults with Marfan syndrome. [21] [22] [23] The primary aims of this ancillary study of subjects participating in the PHN Marfan trial were to compare the HRQOL of children and young adults with Marfan syndrome with those in the general population, compare the impact of beta blocker therapy vs angiotensin II receptor blocker therapy on HRQOL, and describe the relationship between HRQOL and the severity of Marfan-related manifestations and patient-reported symptoms.
Methods
The 608 subjects in the PHN Marfan trial [21] [22] [23] were recruited between 2007 and 2011. At enrollment, subjects were aged 6 months to 25 years, met original Ghent criteria for Marfan syndrome, 24 had aortic root diameter z scores >3.0, and had no previous aortic surgery or dissection. The main trial compared the effects of atenolol vs losartan on aortic root growth over 3 years. 23 Enrollment for this QOL ancillary study began after some subjects had already completed their participation in the main trial, and some sites did not participate in this ancillary study; therefore, 216 subjects from the main trial were ineligible for this ancillary study. Each site's institutional review board approved the QOL study protocol, and written informed consent and/or assent were obtained as appropriate.
The Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales Patient-Self Report [25] [26] [27] [28] [29] [30] [31] [32] is designed for patients ages 5-25 years. Of the 392 eligible for the study overall, 353 were aged 5-25 years and therefore eligible for the PedsQL, and 321 (91%) of these enrolled in this study. The subjects were further divided into the following subgroups by age: 5-7 years (younger children), 8-12 years (older children), 13-18 years (adolescents), and 19-25 years (young adults). We performed QOL assessments at the final trial visit, 36 months after randomization. A structured questionnaire for patient-reported symptoms was administered at each study visit in the main trial, and the data collected at the 36-month visit were used for this study. The questionnaire assessed the frequency and severity of the following symptoms: dizziness, dizziness on standing, fainting/loss of consciousness, shortness of breath, wheezing, chest pain, palpitations, headache, nasal congestion/ head cold, cough, change in how food tastes, stomach pain/ indigestion, nausea, vomiting, constipation, cold hands/feet turning blue/white (Raynaud), muscle pain/cramps, back pain, swelling, mood changes, behavior changes, trouble sleeping, nightmares, tiredness/lack of energy, and other. Symptoms with a 3 or 4 rating on a 1-4 scale were defined as bothersome. In addition, we collected data on the presence of medical issues at each trial visit including neurodevelopmental disorder, psychiatric disorder, ectopia lentis, and skeletal features (pectus carinatum, pectus excavatum, decreased upper-to-lower segment ratio, increased arm span to height ratio, wrist and thumb signs, scoliosis, reduced elbow extension, pes planus with hindfoot deformity, protrusio acetabulae). 24 The 23-item PedsQL Generic Core Scales encompass Physical, Emotional, Social, and School/Work functioning. Items are linearly transformed to a 0 to 100 scale, so that greater scores indicate better HRQOL. Parallel child, teen, and young adult versions of the PedsQL have been developed with similar content and wording across forms to facilitate evaluation of differences across and between age groups as well as tracking longitudinally. To create a Psychosocial Health Summary score, the mean is computed as the sum of the items divided by the number of items in the Emotional, Social, and School/Work functioning scales. The reliability and validity of the PedsQL Generic Core Scales have been demonstrated in healthy and patient populations. [26] [27] [28] [29] [30] [31] A clinically meaningful cutoff score for identification of individuals "at-risk" for significantly impaired HRQOL approximates 1 SD below the mean in the general pediatric population. 27 By design, approximately 15% of the general population would meet this definition of "at-risk."
Statistical Analyses
We examined data collected from the PHN Marfan trial for demographic and clinical differences between subjects who were enrolled vs not enrolled using t tests and c 2 tests. PedsQL scores were compared with published population norms 27 by 1-sample t tests. Frequency (with 95% CI) of PedsQL scores >1 SD below the population sample mean (representing at-risk status for impaired HRQOL) was determined. 27 The impact of select indicators such as treatment arm, age, race/ethnicity, severity of clinical features, and number of patient-reported symptoms and bothersome symptoms on HRQOL was assessed with Spearman correlation coefficients for continuous variables or a Kruskal-Wallis test for categorical variables. Indicators with a P < .1 were entered into the multivariable models. Multivariable general linear models were built using stepwise selection with an entry criteria of 0.15 and an exit criteria of 0.05.
Results
The characteristics of the enrolled and not enrolled groups are shown in Table I . Those who enrolled had smaller aortic root dimensions, but there was no significant difference in the aortic root z scores between groups. There were no differences in age, sex, race/ethnicity, ectopia lentis, neurodevelopmental disorder, or number of skeletal features between groups.
As shown in Table II , self-reported mean PedsQL total, physical functioning, overall psychosocial health, social functioning, and school functioning scores for children and adolescents (5-18 years) with Marfan syndrome were significantly lower than healthy population norms. In contrast, self-reported mean emotional functioning scores were not significantly different from population norms for children 5-7 years and adolescents 13-18 years and only borderline significantly lower in children 8-12 years (P = .05).
For young adults (19-25 years), the mean PedsQL scores for physical functioning tended to be lower than population norms (P = .06), and the mean scores for total, overall psychosocial Volume 204 • January 2019 health, emotional functioning, and school/work functioning were significantly higher compared with healthy population norms.
The percentage of subjects at-risk for impaired HRQOL was greater across most domains than in the general population (Table III) . For children and adolescents <18 years, selfreported HRQOL scores were in the impaired range for physical and psychosocial HRQOL in 34% and 27% of subjects, respectively. The proportion of self-reported physical scores in the impaired range was greater in adolescents (43%) than in younger children (5-7 years, 23%). Although 35% of young adults (19-25 years) had scores in the impaired range for physical functioning, overall psychosocial health as well as emotional, social, and school/work functioning were comparable with the general population based on the percentage of subjects at risk. *Cutoff score for "at-risk" status for significantly impaired quality of life defined as >1 SD below the mean in the general pediatric population. Approximately 15% of the general population would meet this definition of "at risk." 27 If the CI includes 15%, there is no significant difference in percentage impaired compared with the healthy population. If the lower limit of the CI is >15%, percentage impaired is significantly worse than the healthy population, and if the upper limit is <15%, percentage impaired is significantly better than the healthy population.
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In univariate analysis, male sex had a negative impact on psychosocial HRQOL, with female subjects having greater psychosocial HRQOL scores by 3.87 points (P < .001). HRQOL across multiple domains correlated inversely with frequency of patient-reported symptoms (r = 0.30-0.38, P < .0001). There were no significant differences in HRQOL scores between treatment arms (atenolol vs losartan). HRQOL also was not associated with aortic root z score, number of skeletal features, or presence of ectopia lentis. Children and adolescents (≤18 years of age) with reported neurodevelopmental disorder (mainly learning disability, attention-deficit/hyperactivity disorder [ADHD]) had lower mean self-reported HRQOL scores (5.5-7.4 points lower, P < .04).
The results of the multivariable model for subjects ≤18 years of age are shown in Table IV . Age, sex, number of patientreported symptoms, and neurodevelopmental disorder (ADHD requiring medication and learning differences requiring special education or services) were significant independent predictors of HRQOL.
Discussion
Few studies have examined the HRQOL of children and adolescents with Marfan syndrome. In our large cohort of 321 young subjects participating in the PHN Marfan trial, children and adolescents with Marfan syndrome reported lower overall, psychosocial, and physical HRQOL across multiple domains and age groups, compared with the healthy population. Our results are in contrast to a small study of children and adolescents with Marfan syndrome showing no significant impairment in HRQOL 2 and more consistent with a number of studies in adults with Marfan syndrome that have shown impaired HRQOL. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Although young adults with Marfan syndrome in our study had significant impairment in physical HRQOL, they had significantly greater total and psychosocial HRQOL scores compared with the healthy population, an unexpected finding. This relative sparing of psychosocial HRQOL in young adults also was observed in patients living with severe congenital heart disease (Fontan circulation for single-ventricle heart disease). 33 Although physical and psychosocial HRQOL was reduced in younger children who underwent a Fontan procedure, in patients ≥16 years, only physical but not psychosocial HRQOL was reduced, and the greater predictor of impaired HRQOL was lower cognitive function rather than lower peak exercise capacity. 33 Perhaps young adults have developed coping skills that allow for normal psychosocial functioning despite their physical limitations. Most published HRQOL studies in adults with Marfan syndrome have focused on older rather than young adults, which may account for the differences seen in our study.
Among the children and adolescents in our study, psychosocial HRQOL was lower than in the general population. Approximately 1 in 4 subjects reported significant impairment in psychosocial HRQOL. A systematic review of the psychosocial aspects of adolescents and adults living with Marfan syndrome found that Marfan syndrome had a significant negative impact on HRQOL.
14 Rand-Hendriksen et al also found that adults with Marfan syndrome had reduced HRQOL, comparable with those with other chronic disorders and disabilities. 10 With respect to social QOL, nearly 1 in 3 adults with Marfan syndrome reported feeling discriminated against or socially devalued because of having Marfan syndrome as reported by Peters et al. [3] [4] [5] Our findings suggest that younger children and adolescents with Marfan syndrome are also at risk for impaired psychosocial HRQOL. Perhaps most worrisome about our data is the observation that HRQOL was low, despite the fact that the average age of our participating subjects was in the preadolescent period. Given the body image and social concerns associated with the middle school and high school years, psychosocial HRQOL is likely to be even worse during these time periods for youth with Marfan syndrome, with the potential for major negative ADD, attention deficit disorder. *Slope for continuous predictors, for example, magnitude of increase in HRQOL score for each year of age; difference for categorical predictors, for example, magnitude of increase in HRQOL score for female compared with male subjects.
impact on school performance, social performance, and general feelings of self-worth and well-being. There are important age-related differences between our results and those of previously published studies. Some of these differences can be explained by selection bias among the different studies. For example, the selection criteria for the PHN Marfan trial excluded individuals with very mild and very severe cardiovascular disease. The 1 previous study that focused on young children was a small study of only 46 subjects, therefore not reflecting the broader population of children with Marfan syndrome. Our larger study better reflects the broader population of children and adolescents, despite the limitations in our cohort relative to the mild and severe ends of the spectrum of cardiovascular disease.
The young adults in our cohort had total and psychosocial HRQOL scores greater than those for the general population. In addition to better coping skills noted previously, it is likely that the entry criteria selected for more mildly affected adults, particularly because patients with a previous history of aortic surgery were excluded. As such, our results for young adults may not be representative of the broader population of young adults with Marfan syndrome. Furthermore, most of the QOL studies previously published had small sample sizes, low participation rates, and older age; and older adults are more likely to have more involved medical issues involving multiple systems and more likely to experience pain and other psychosocial issues. 14 In our study, a greater number of self-reported symptoms and a history of a neurodevelopmental disorder had the greatest negative associations with HRQOL. There were no significant associations between HRQOL and treatment arm, aortic root z score, number of skeletal features, or presence of ectopia lentis. This is consistent with studies in adults that have reported reduced HRQOL unrelated to medical severity or biomedical criteria. Symptoms such as pain, fatigue, and psychological distress seem to have greater impact on HRQOL than objective biomedical findings. 6, 10, [12] [13] [14] [15] [16] In a recent large cohort of 389 patients with Marfan syndrome in the GenTAC registry (mean age 41 years, 51% men, 92% white, and 65% college graduates), HRQOL was below the population norm. Better HRQOL was independently associated with socioeconomic factors (private health insurance, full-time employment), rather than factors related to general health or severity of Marfan syndrome. 20 The association between reported neurodevelopmental disorder, mainly learning disability and ADHD, and HRQOL in our study was not surprising. Gritti et al recently published a critical review of the literature on psychiatric and neuropsychological issues in patients with Marfan syndrome. 34 Early studies examining the neuropsychological aspects of Marfan syndrome by Hofman et al suggest that although individuals with Marfan syndrome may have average intellectual and gross motor development, 50% had neuropsychological deficits, including learning disability, ADHD, neuromaturational immaturity, and/or a performance IQ score different from their verbal score by more than 20 points. 35 Lannoo et al reported problems with sustained visual attention and visual reconstruction over and above visual acuity problems and other phenomena associated with Marfan syndrome. 36 In addition, they noted that those with hand-wrist hypermobility seemed at particular risk for difficulties with tasks that involve writing. Neurodevelopmental deficits including ADHD are known to impact physical and psychosocial HRQOL negatively, as shown by 2 previous studies using the PedsQL. 37, 38 In our study, male sex was significantly associated with worse psychosocial HRQOL, consistent with a previous study of adults with Marfan syndrome. 9 This finding should alert parents and healthcare providers to the increased risk for worse psychosocial HRQOL in male patients.
The difference between physical severity and subjective severity perception illustrates that patients may perceive the disorder differently from professionals. 6 This is important for healthcare providers to recognize when discussing patientreported symptoms in clinical practice. Patient-reported HRQOL should be incorporated into clinical practice to ensure the patient's perspective is included in clinical decisionmaking. Self-report, rather than proxy report, is considered the gold standard for assessment of HRQOL in children and adolescents; however, we often rely on proxy reporting in pediatric practice. For children with chronic conditions, proxies tend to report lower HRQOL scores than the children themselves. 29 For example, patients with significant pain or emotional distress are more susceptible to under-recognition of subjective aspects of well-being by parents and healthcare providers. 39 Neuropsychological evaluation to identify problems such as ADHD and learning difficulties, as well as early interventions, may further improve HRQOL in children growing up with Marfan syndrome.
Individuals with milder degrees of aortic dilation and those with more severe aortic disease already requiring surgery were excluded. Furthermore, there were differences in aortic root dimension but not aortic root z score between those who enrolled in this HRQOL study and those who did not. Hence, the findings in our study may not reflect the broader population of children and young adults with Marfan syndrome. Revised diagnostic criteria for Marfan syndrome were published after initiation of the PHN Marfan trial. We retrospectively compared the original and revised Ghent diagnostic criteria in the enrolled subjects. Nearly all the randomized subjects (603 of 608) satisfied both the original and revised criteria. 22 Based on this analysis, we surmise that there are likely no major implications for the broader application of these results to individuals who meet current criteria for Marfan syndrome. This study should prompt healthcare providers of children and adolescents with Marfan syndrome to increase their attention to symptoms and neurodevelopmental issues as well as to provide opportunities for therapy to improve overall HRQOL for young people with Marfan syndrome. 
